A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction

心肌细胞中应激诱导的启动子暂停释放程序可预防心肌梗死

基本信息

项目摘要

ABSTRACT The intersection of genotoxic stress and altered transcriptional programs impacts numerous disease and disease risk events, but surprisingly little is mechanistically known in this regard, particularly with respect to risk alleles for myocardial infarction. Based on our initial data, we can confirm that a single base alteration in a CTCF site in the SIRT1 promoter can increase the risk of MI. We will investigate the hypothesis that this is based on the functional importance of induced binding of CTCF to in response to hypoxia or genotoxic stress to the cognate site in the SIRT1 promoter, licensing a promoter pause release that results in an acute stimulation of SIRT1 transcription. The proposed research is directed at revealing a previously overlooked strategy for signal-dependent transcriptional regulation based on redistribution of the critical chromosomal architectural protein - CTCF- in activation of a large promoter pause release program with important biological consequences, including the gene encoding critical regulator - SIRT1. We will investigate the hypothesis that stress-induced increased transcription of SIRT1 and a global genomic program of response to oxidative stress in cardiomyocytes is mediated by CTCF promoter recruitment and, in part, by long distance interactions based on liquid-liquid phase separation of CTCF and lncRNAs in cardiomyocytes, which is lost in MI risk allele carriers. We will investigate the stress-induced transcriptional program in iPSC-derived, genome-sequenced cardiac myocytes and the test the hypothesis by assessing effects of introducing the risk allele in mice. With the availability of iPSCs harboring the causative SNP for the SIRT1 risk allele, we are now in a position to delve into the precise mechanism of these events, and assess the possibility that there is a large cardiomyocyte pause-release program important with respect to cardiac response to acute insults. The idea that a key arbiter of chromosome architecture is regulated by phosphorylation of a key architectural protein, binding to a set of promoters harboring weak sites for CTCF and licensing increased transcription based of promoter pause release events reveals an unappreciated signal-dependent mechanism for controlling important biological program.
摘要 遗传毒性应激和改变的转录程序的交叉影响许多疾病和 疾病风险事件,但令人惊讶的是,在这方面,特别是关于 心肌梗死的危险等位基因根据我们的初步数据,我们可以确认, SIRT 1启动子中的CTCF位点可增加MI的风险。我们将研究这是一个假设, 基于CTCF的诱导结合在响应缺氧或遗传毒性应激中的功能重要性, 与SIRT 1启动子中的同源位点连接,从而允许启动子暂停释放,导致急性免疫应答。 SIRT 1转录的刺激。这项研究旨在揭示一个以前被忽视的问题。 基于关键染色体重分布的信号依赖性转录调控策略 建筑蛋白- CTCF-在激活一个大的启动子暂停释放程序与重要的生物学 结果,包括基因编码的关键调节-SIRT 1。我们将研究一个假设, 应激诱导SIRT 1转录增加和氧化应激应答的全球基因组程序 在心肌细胞中,通过CTCF启动子募集介导,部分通过基于 心肌细胞中CTCF和lncRNA的液-液相分离,这在MI风险等位基因中丢失 载波我们将在iPSC衍生的基因组测序中研究应激诱导的转录程序, 心肌细胞,并通过评估在小鼠中引入风险等位基因的影响来检验假设。与 携带SIRT 1风险等位基因的致病SNP的iPSC的可用性,我们现在能够 深入研究这些事件的确切机制,并评估有很大的可能性, 心肌细胞暂停释放程序对于心脏对急性损伤的反应很重要。这个想法 染色体结构的关键仲裁者是由关键结构蛋白的磷酸化调节的, 结合到一组携带CTCF弱位点的启动子上, 启动子暂停释放事件揭示了一种不受重视的信号依赖性机制, 重要的生物学项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL G ROSENFELD其他文献

MICHAEL G ROSENFELD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL G ROSENFELD', 18)}}的其他基金

Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease
病毒 IncRNA 调节与散发性阿尔茨海默病相关的宿主基因组转录程序
  • 批准号:
    10446865
  • 财政年份:
    2022
  • 资助金额:
    $ 66.85万
  • 项目类别:
Viral IncRNAs Regulate Host Genomic Transcriptional Programs Associated with Sporadic Alzheimer's Disease
病毒 IncRNA 调节与散发性阿尔茨海默病相关的宿主基因组转录程序
  • 批准号:
    10650398
  • 财政年份:
    2022
  • 资助金额:
    $ 66.85万
  • 项目类别:
Revealing the roles of HSV1 lytic and latent transcripts in AD pathogenesis and therapy
揭示 HSV1 裂解转录物和潜伏转录物在 AD 发病机制和治疗中的作用
  • 批准号:
    10621810
  • 财政年份:
    2021
  • 资助金额:
    $ 66.85万
  • 项目类别:
Regulatory Landscape of the Aging Human Ovary
人类卵巢衰老的调控景观
  • 批准号:
    10441547
  • 财政年份:
    2020
  • 资助金额:
    $ 66.85万
  • 项目类别:
Regulatory Landscape of the Aging Human Ovary
人类卵巢衰老的调控景观
  • 批准号:
    10646190
  • 财政年份:
    2020
  • 资助金额:
    $ 66.85万
  • 项目类别:
Regulatory Landscape of the Aging Human Ovary
人类卵巢衰老的调控景观
  • 批准号:
    10264170
  • 财政年份:
    2020
  • 资助金额:
    $ 66.85万
  • 项目类别:
Regulatory Landscape of the Aging Human Ovary
人类卵巢衰老的调控景观
  • 批准号:
    10091772
  • 财政年份:
    2020
  • 资助金额:
    $ 66.85万
  • 项目类别:
Combinatorial regulation of the enhancer codes in senescence
衰老过程中增强子密码的组合调控
  • 批准号:
    10152492
  • 财政年份:
    2019
  • 资助金额:
    $ 66.85万
  • 项目类别:
A stress-induced promoter pause release program in cardiomyocytes protecting against myocardial infarction
心肌细胞中应激诱导的启动子暂停释放程序可预防心肌梗死
  • 批准号:
    10318093
  • 财政年份:
    2019
  • 资助金额:
    $ 66.85万
  • 项目类别:
Combinatorial regulation of the enhancer codes in senescence
衰老过程中增强子密码的组合调控
  • 批准号:
    10017129
  • 财政年份:
    2019
  • 资助金额:
    $ 66.85万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 66.85万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了